Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07845552 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy

StatusNot Yet Recruiting
PhasePhase 4
Started2026-10
View on ClinicalTrials.gov ↗
The goal of this clinical trial is to learn how quickly omalizumab begins to work in people with food allergy. The main question it aims to answer is: * Does omalizumab begin to work as early as 2 to 4 weeks after after starting treatment in people with food allergy? Researchers will compare each participant's food challenge results at baseline before starting omalizumab, 2 to 4 weeks after starting omalizumab, and 4 to 6 months after starting omalizumab treatment. Participants will: * Have a baseline food challenge before starting omalizumab. * Start omalizumab treatment as prescribed by the participant's doctor as part of regular clinical care. * Have food challenges 2 to 4 weeks after starting omalizumab and again 4 to 6 months after starting omalizumab. * Have skin prick testing and blood tests at study visits.
Trial Details
NCT Number NCT07845552
Lead Sponsor Johns Hopkins University
Conditions Food Allergy
Enrollment 20 participants
Start Date 2026-10
Primary Completion 2028-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-09-29